NIACINAMIDE 4% / TAZAROTENE 0.1%- niacinamide 4% / tazarotene 0.1% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

NIACINAMIDE 4% / TAZAROTENE 0.1%

Directions for use

s

Sincerus Florida, LLC adverse reactions.

g

Active Inactive

h

NDC 72934-2061-2
NIACINAMIDE 4 / TAZAROTENE 0.01
Cream 30gm

z

NIACINAMIDE 4% / TAZAROTENE 0.1% 
niacinamide 4% / tazarotene 0.1% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2161
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE0.1 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2161-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2161)

Revised: 4/2019
Document Id: 8738c9c8-17b2-b7b7-e053-2a91aa0acdfb
Set id: 8738c9c8-17b1-b7b7-e053-2a91aa0acdfb
Version: 1
Effective Time: 20190423
 
Sincerus Florida, LLC